Price Over Earnings Overview: Amgen
In the current session, Amgen Inc. (NASDAQ:AMGN) is trading at $229.08, after a 0.65% drop. Over the past…
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ:AMGN) concealed the dispute over…
Nasdaq Futures Climb Solidly After Past Week’s Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per patient monthly when it launched in 2021.
A Look Into Amgen’s Debt
Shares of Amgen Inc. (NASDAQ:AMGN) fell by 17.83% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Lottery.com, Inc. Appoints Mr. Mark Gustavson As New CEO Effective February 1, 2023, Will Also Serve As The Principal Financial/Accounting Officer Of The Company Until A Replacement Is Found; CEO Sohail S. Quraeshi And CFO Edward K. Moffly Resign From…
Lottery.com, Inc. (NASDAQ:LTRY)(NASDAQ:LTRYW) (the "Company" or "Lottery.com"), today announced the appointment of Mr. Mark Gustavson as its new Chief Executive Officer.
Lottery.Com, Inc. has
Amgen Nearing Buy Point With Great Dividend and Fundamentals
Amgen Inc. (NASDAQ: AMGN) is right near the bottom of a more than 6-year trend channel.
Top 5 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Truist Securities Maintains Hold on Amgen, Lowers Price Target to $260
Truist Securities analyst Robyn Karnauskas maintains Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $280 to $260.
Top 5 Health Care Stocks That May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.